Skip links and keyboard navigation

    Media Statements

    Coat of ArmsMedia Release
    JOINT STATEMENT
    Premier and Minister for the Arts
    The Honourable Annastacia Palaszczuk
    Minister for Innovation, Science and the Digital Economy and Minister for Small Business
    The Honourable Leeanne Enoch

    Golden Biotech to work with QUT researchers on Alzheimer’s cure

    JOINT STATEMENT

    Premier and Minister for the Arts
    The Honourable Annastacia Palaszczuk

    Minister for Innovation, Science and the Digital Economy and Minister for Small Business
    The Honourable Leeanne Enoch

    Friday, June 23, 2017

    Golden Biotech to work with QUT researchers on Alzheimer’s cure

    A Taiwanese biotech company will work with Queensland researchers to determine if a new chemical entity – derived from a mushroom – could potentially treat Alzheimer’s disease.

    Premier Annastacia Palaszczuk said Taiwanese biotech Golden Biotechnology Corporation was collaborating with the Institute of Health and Biomedical Innovation (IHBI) at QUT to conduct pre-clinical testing of a chemical compound called Antroquinonol, which is showing promise as a way to prevent and combat Alzheimer’s.

    Ms Palaszczuk, who this week attended the international BIO 2017 conference in San Diego, said Golden Biotechnology Corporation was one of the three recipients of last year’s Advance Queensland Johnson & Johnson Innovation QuickFire Challenge.

    “The global health innovation competition drew nearly 100 applications from around the world. Out of that we got three recipients across three categories - medical devices, pharmaceuticals and consumer healthcare with each receiving $100,000,” Ms Palaszczuk said.

    “A condition of the challenge was that the recipients had to spend their award money in Queensland on research and commercialisation services.”

    Golden Biotechnology Corporation won the Pharmaceuticals category and as required, will now spend their $100,000 in prize money in Queensland working with IHBI.

    Antroquinonol is derived from Antrodia camphorata, a mushroom native to Taiwan which has long been used as a traditional remedy and preventative herbal supplement.

    Minister for Innovation, Science and the Digital Economy Leeanne Enoch – who also attended BIO 2017 – said research findings by the Institute of Brain Science at Taiwan’s National Yang-Ming University found that Antroquinonol improved learning and memory in mice with Alzheimer’s disease.

    “The next stage in the development of a potential therapy is to do the all-important pre-clinical testing before moving to human trials,” Ms Enoch said.

    “This is where the Queensland University of Technology’s IHBI comes into the picture. It has the state-of-the-art equipment and expertise to do this all important work.

    “The work will be undertaken at IHBI under the direction of Professor Lyn Griffiths and Dr Francesca Fernandez, in partnership with Golden Biotechnology Corporation. The work is part of a larger contract being supported by Golden Biotechnology Corporation as well as the Palaszczuk Government.”

    Golden Biotechnology Corporation’s General Manager Dr Miles Chih-Ming Chen said if the results of the study were promising, Golden Biotechnology intended to move to human clinical trials.

    “We are very hopeful. We appreciate the support we’ve received from the Queensland Government and Johnson & Johnson Innovation. Queensland is quickly gaining a global reputation for the quality of its translational research capability, and for building an environment committed to supporting the life sciences industry,” Dr Chen said.

    “This really gives us a lot of confidence as a company working in Queensland to progress our product.”

    Alzheimer’s disease is the most common cause of dementia. More than 413,000 Australians are living with dementia and this is expected to increase to over half a million by 2025. According to a University of Canberra report, the cost of dementia to the Australian economy in 2016 was over $14 billion.

    The Palaszczuk Government provided the prize money for the Advance Queensland Johnson & Johnson Innovation QuickFire Challenge under its $420 million whole-of-government Advance Queensland initiative.

    Johnson & Johnson Innovation also provided mentoring, business development training and scientific support to develop the collaboration between QUT and Golden Biotechnology Corporation.

    Johnson & Johnson Innovation opened at QUT last year, located at IHBI on the Queensland University of Technology’s Kelvin Grove campus.

    Celebrating its first anniversary this week, the office provides the all-important critical mass for the successful development and growth of Queensland’s life sciences industry.

    The Premier and Ms Enoch were in the US this week leading the Queensland industry delegation to the 2017 BIO International Convention, the world’s biggest life sciences conference.

    Media Contact:                                                                     

    Premier’s Office:  0417 272 875

    Minister Enoch’s Office: 0412 393 909